基于二次审方软件对静脉用药浓度与滴速药学干预的模式实践

    Model Practice of Pharmaceutical Intervention on Intravenous Drug Concentration and Drip Rate Based on Secondary Prescription Review Software

    • 摘要:
      目的 针对医院药学医嘱审核中静脉用药无法有效审核的问题,开发二次审方软件并开展对静脉用药浓度与滴速药学干预实践,探究其在合理用药中的作用与成效。
      方法  静脉用药调配中心审方药师依据药品说明书、指南等相关信息,并依托医院信息系统的基础信息,同时结合当前处方和医嘱审核中的问题,有针对性地进行二次审方软件的研发设计。针对静脉用药的浓度、滴速信息予以规范,确立审核规则,设计审方模块,对存在的不适宜用药类别实施有效审核,对软件的使用效果进行评价。
      结果 开发的二次审方软件能够切实审查出静脉用药浓度和滴速的不合理现象,对存在不适宜用药的类别进行有效甄别,从而提升医嘱的合格率。
      结论 二次审方软件的运用,能够为临床给予及时、精确的用药警示,有效干预不合理的医嘱,填补现有审方软件的缺陷,提高审方工作的效率。为临床用药提供坚实有力的指导,保证临床用药的合理性,彰显药师的服务价值。

       

      Abstract:
      OBJECTIVE Aiming at the problem that intravenous medication cannot be effectively reviewed in the medical order review of the hospital pharmacy, this study intends to develop a secondary prescription review software, carry out pharmaceutical intervention practices on the concentration and drip rate of intravenous drugs, and explore its role and effect in rational drug use.
      METHODS pharmacy intravenousadmixture services prescription review pharmacists developed and designed a secondary prescription review software according to the relevant information such as drug instructions and guidelines, the basic information of hospital information system, and the problems encountered in the current prescription and medical order review. According to the concentration and drip rate information of intravenous drugs, the review rules were established, and the review module was designed to carry out effective review of the unsuitable drugs. Evaluate the effectiveness of the software.
      RESULTS The software developed for secondary prescription review could effectively examine the unreasonable phenomenon of intravenous drug concentration and drip rate, and effectively screen the category of inappropriate drugs, so as to improve the qualified rate of medical orders.
      CONCLUSION The application of secondary prescription review software can give timely and accurate drug warnings for clinical use, effectively intervene in unreasonable medical orders, fill the defects of existing prescription review software, and improve the efficiency of prescription review work. To provide solid and powerful guidance for clinical drug use, ensure the rationality of clinical drug use, and highlight the service value of pharmacists.

       

    /

    返回文章
    返回